Myeloma’s Most Effective New Drugs Require a Hospital Stay to Start, and That Is Keeping Them Out of Reach for Rural Patients

Bispecific antibodies work in advanced myeloma, but startup requirements keep them at academic centers. New guidance aims to close the community gap.

Have A Referral?